Levodopa FDA Link Generic

The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.

Also Known As:

L Dopa; Larodopa; 3-Hydroxy-L-tyrosine; Dopaflex; Dopar; L-3,4-Dihydroxyphenylalanine; Levopa; 3 Hydroxy L tyrosine; L 3,4 Dihydroxyphenylalanine; L-Dopa

Pharmalogical Action Categories:

Antiparkinson Agents
Dopamine Agents

Organic Chemicals: 140
- Amines: 4925
  - Catecholamines: 15823
    - Dihydroxyphenylalanine: 1507
      - Levodopa: 12961
- Hydrocarbons: 1726
  - Cyclic Hydrocarbons: 96
    - Aromatic Hydrocarbons: 295
      - Benzene Derivatives: 17
        Phenols: 702
        Catechols: 122
        Catecholamines: 15823
        Dihydroxyphenylalanine: 1507
        Levodopa: 12961
Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 31329
  - Cyclic Amino Acids: 3
    - Aromatic Amino Acids: 484
      - Tyrosine: 10679
        Dihydroxyphenylalanine: 1507
        Levodopa: 12961
      - Phenylalanine: 4162
        Dihydroxyphenylalanine: 1507
        Levodopa: 12961

228 Study Investigators Selected Research

228 Study Investigators Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure